Novavax, Serum seek emergency use approval from WHO for Covid vaccine

[ad_1]


Novavax and SII made regulatory submissions to WHO for EUL of Novavax’s recombinant nanoparticle protein-based Covid-19 vaccine candidate with Matrix-M adjuvant.

[ad_2]

Source link